S112: TISAGENLECLEUCEL IN PEDIATRIC AND YOUNG ADULT PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL): FINAL ANALYSES FROM THE ELIANA STUDY

• S. Rives,
• S. L. Maude,
• H. Hiramatsu,
• A. Baruchel,
• P. Bader,
• H. Bittencourt,
• J. Buechner,
• T. Laetsch,
• B. De Moerloose,
• M. Qayed,
• H. E. Stefanski,
• K. L. Davis,
• P. L. Martin,
• E. Nemecek,
• C. Peters,
• G. Yanik,
• A. Balduzzi,
• N. Boissel,
• S. L. Khaw,
• J. Krueger,
• J. Levine,
• S. Davies,
• G. D. Myers,
• A. Yeo,
• D. O’Donovan,
• R. Ramos,
• M. Pulsipher,
• S. Grupp

Affiliations

S. Rives

1 Department of Pediatric Hematology – Oncology, Hospital Sant Joan de Déu Barcelona, and Institut de Recerca Sant Joan de Déu, Barcelona, Spain

S. L. Maude

2 Division of Oncology, Center for Childhood Cancer Research and Cancer Immunotherapy Program, Children’s Hospital of Philadelphia and Department of Pediatrics, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America

H. Hiramatsu

3 Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan

A. Baruchel

4 University Hospital Robert Debré (APHP) and Université de Paris, Paris, France

P. Bader

5 Division of Stem Cell Transplantation and Immunology, Hospital for Children and Adolescents, University Hospital Frankfurt, Frankfurt, Germany

H. Bittencourt

6 Department of Pediatrics, Faculty of Medicine, University of Montreal, and the Hematology Oncology Division and Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire Sainte-Justine Research Centre, Montreal, QC, Canada

J. Buechner

7 Department of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo, Norway

T. Laetsch

2 Division of Oncology, Center for Childhood Cancer Research and Cancer Immunotherapy Program, Children’s Hospital of Philadelphia and Department of Pediatrics, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America

B. De Moerloose

8 Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium

M. Qayed

9 Aflac Cancer and Blood Disorders Center, Emory University, Atlanta, GA

H. E. Stefanski

10 National Bone Marrow Donor Program, Be the Match, Division of Pediatric Blood and Marrow Transplant, University of Minnesota, Minneapolis, MN

K. L. Davis

11 Division of Hematology, Oncology and Stem Cell Transplant, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA

P. L. Martin

12 Pediatric Transplant and Cellular Therapy, Duke University Medical Center, Durham, NC

E. Nemecek

13 Oregon Health and Science University, Portland, OR, United States of America

C. Peters

14 Stem Cell Transplantation Unit, St. Anna Children’s Hospital, Vienna, Austria

G. Yanik

15 Department of Pediatrics, University of Michigan Medical Center, Ann Arbor, MI, United States of America

A. Balduzzi

16 Clinica Pediatrica Università degli Studi di Milano Bicocca, Fondazione MBBM, Ospedale San Gerardo, Monza, Italy

N. Boissel

17 Saint-Louis Hospital (APHP) and Université de Paris, Paris, France

S. L. Khaw

18 Children’s Cancer Centre, Royal Children’s Hospital and Murdoch Children’s Research Institute, Parkville, VIC, Australia

J. Krueger

19 Division of Haematology/Oncology/Bone Marrow Transplantation, Department of Paediatrics, The Hospital for Sick Children, Toronto, ON, Canada

J. Levine

20 Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY

S. Davies

21 Cincinnati Children’s Hospital Medical Center, Cincinnati, OH

G. D. Myers

22 Children’s Mercy Hospital and Clinics, Kansas City, MO

A. Yeo

23 Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States of America

D. O’Donovan

24 Novartis Pharmaceuticals Corporation, Dublin, Ireland

R. Ramos

23 Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States of America

M. Pulsipher

25 Division of Pediatric Hematology and Oncology, Intermountain Primary Children’s Hospital, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT, United States of America

S. Grupp

2 Division of Oncology, Center for Childhood Cancer Research and Cancer Immunotherapy Program, Children’s Hospital of Philadelphia and Department of Pediatrics, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America